Abstract
Pharmaceutical prices in the United States, both proprietary brand names and generics have skyrocketed over the last two decades. The prices of generics, although there are multiple worldwide manufacturers, have gone up exponentially. One of the significant costs drivers in the United States are the PBM,’s pharmacy benefits managers, middlemen. Author presentation will document this and a solution to the problem will be presented. He will show that the repeal of the PBM Safeharbor granted by the federal government in two, has resulted in major price increases. If the safe harbor is removed, prices will plummet to a stable point.He will show that the repeal of the PBM Safeharbor granted by the US federal government in 2002, has resulted in major price increases. If the PBM Safe-harbor is removed, prices will plummet to a stable point as determined by market forces.
Paper version not known (Free)
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.